[Effect of the thymic factor on blood coagulation and fibrinolysis in thymectomized rats].
Kuznik. B I BI; Tsybikov. N N NN; Molchanova. N L NL; Morozov. V G VG; Khavinson. V Kh VKh
Key Findings
- Thymectomy in adult rats leads to hypercoagulation and reduced fibrinolysis.
- The clotting cascade speeds up (shortened first phase) and fibrinolytic agents drop while antiplasmin rises.
- A short course of thymic factor peptide restores most coagulation and fibrinolysis parameters to normal.
Practical Outcomes
- For biohackers, this suggests thymalin might help balance clotting and clot breakdown, especially in situations where the immune/thymic function is compromised. However, the evidence is limited to rats, so any human protocol would be experimental and should start with low doses and careful monitoring of blood‑clotting markers.
Summary
In rats that had their thymus removed, blood clotting became too fast and the ability to break down clots slowed down. Giving them a low‑molecular‑weight thymic peptide (similar to thymalin) for five days mostly fixed these blood‑clotting problems.
Abstract
Hypercoagulation and fibrinolysis inhibition are seen in adult rats 6 to 6 1/2 months after thymectomy. Hemocuagulation accelerating is caused by the shortened 1st phase of the blood coagulation process. Fibrinolysis delay is partially produced by a decrease in the fibrinalytic agent concentration and smooth elevation of the antiplasmin level. The most part of the coagulogram indices and fibrinolysis activation returns to normal in operated animals following the injection of a low-molecular polypeptide thymic factor within 5 days.
Study Information
pubmed
1982